COVID-19
Fujitsu to Detect and Analyze New COVID-19 Drugs by Leveraging World’s Fastest Supercomputer
Fujitsu Japan Limited (Tokyo, Japan), along with the Research Center for Advanced Science and Technology (RCAST) at the University of Tokyo (Tokyo, Japan), has initiated a new...
Latest COVID-19 News
- COVID-19 Dual-Antibody Therapies Found Effective Against SARS-CoV-2 Variants in Animal Study
- New Immunotherapy Platform Deploys Engineered Molecules to Inhibit SARS-CoV-2 Infection and Remove COVID-19 Infected Cells
- Lung Ultrasound Used to Manage Critically Ill COVID-19 Patients Leads to Huge Time Savings as Compared to Chest CT
- Gilead’s Remdesivir Reduced Mortality in Hospitalized COVID-19 Patients, Shows Real-World Data Analyses
- Tapeworm Drug Niclosamide Shows Strong Antiviral Effect as Potential New Treatment for COVID-19
- PET Imaging Can Accurately Measure Cognitive Impairment in COVID-19 Patients
- First-in-Class Nasal Spray Could Both Treat and Prevent COVID-19
- AI-Enhanced EKG Can Be Used as Rapid, Reliable COVID-19 Screening Test to Rule out Infection
- Getinge's AI Solution Helps Hospitals Address Post COVID-19 Pandemic Surgical Backlog
- Oral COVID-19 Vaccine Proves an Effective Booster in Preclinical Trial
- Engineered IgM Antibody Administered Intranasally May Be More Potent at Inhibiting SARS-CoV-2 and Its Variants than Current Antibody Therapies
- Experimental Drug TEMPOL May Be Promising Oral Antiviral Treatment for COVID-19, Suggests New Research
- Next-Generation COVID-19 Antibody to Neutralize SARS-CoV-2 Mutated Variants and Allow Injectable Dosing
- New Tool Uses Deep-Learning AI Technology to Accurately Assess Severity of Lung Infections in COVID-19 Patients
- Intelligent Lung Ultrasound Provides Crucial Support for COVID-19 Testing Within Minutes
- Cutting-Edge MRI Method Reveals Persistent COVID-19 Lung Damage Overlooked by Routine CT
- New Drug That Blocks Multiple SARS-CoV-2 Variants Could Be a Game-Changer in Treating COVID-19 Infection
- Machine Learning Model Predicts Treatment with Dialysis or Death for Hospitalized COVID-19 Patients
- GlaxoSmithKline and Vir Biotechnology’s COVID-19 Antibody Drug Granted FDA Emergency Use Authorization
- Inhalable Nanobody-Based Treatment Administered at Ultra-Low Doses Could Prevent and Treat SARS-CoV-2 Infections
- First-Ever Peptide-Based Drugs Could Both Prevent and Treat COVID-19
- World’s First COVID-19 Vaccine Booster Study of Seven Vaccines to Provide Vital Data on Impact of Third Dose on Immune Response
- AI Supported Predictors of Cardiac-Related COVID-19 Mortality Revealed in New Study
- World’s First Study to Deliberately Infect Healthy Volunteers with SARS-CoV-2 for Investigation of T Cell Response to COVID-19
- AI-for-COVID19 Imaging Archive Platform Enables Sharing of Radiographic Images from COVID-19 Patients and Development of AI Solutions
- Echocardiography Imaging Can Identify COVID-19 Patients Predisposed to Heart Failure Who Face Higher Mortality Risk
- Ultrasound Stimulation Reduces COVID-19-Related Inflammation and Decreases Length of Hospital Stays
- AI Tool Uses Chest X-Rays to Identify COVID-19 Patients Likely to Develop Life-Threatening Complications with 80% Accuracy
- AI Analytics Predict Daily Trajectory of COVID-19 Patients in Intensive Care Units